Fluid overload-associated large B-cell lymphoma: two case report and review of literature [0.03%]
与液体过负荷相关的大B细胞淋巴瘤：两例报告及文献回顾
Liudi Chang,Zhaobo Yang,Cuicui Yang et al.
Liudi Chang et al.
Background: Fluid overload-associated large B-cell lymphoma (FO-LBCL) is an exceptionally rare lymphoma characterized by predominant involvement of serous body cavities-such as the pleura, peritoneum, and pericardium-in t...
Clinical characteristics and treatment outcomes of cervical high-grade squamous intraepithelial lesions in women under 25 years: a retrospective cohort study [0.03%]
一项回顾性队列研究：25岁以下女性宫颈高度鳞状上皮内病变的临床特征及治疗结局
Yanmei Liu,Ke Peng,Shujun Gao
Yanmei Liu
Objectives: Limited data are available regarding the clinical characteristics and treatment outcomes of cervical HSIL in women under 25, particularly in Asian populations. This study aimed to investigate the clinical feat...
Dual malignancies: a case report of the sequential occurrence of a trichilemmal tumor and breast carcinoma in a 56-year-old female [0.03%]
双原发恶性肿瘤：1例女枕顶部毛矩阵瘤和乳腺癌连续发生的病例报告
Bhargav Vuppumalla,A Ravichandran,M Manickavasagam et al.
Bhargav Vuppumalla et al.
The authors present a rare case of the sequential occurrence of a malignant trichilemmal tumor (MPTT) and invasive ductal carcinoma of the breast in a 56-year-old woman. The patient initially presented with a palpable breast lump and a long...
Ivonescimab for EGFR-mutant lung adenosquamous carcinoma after multiline therapy: A case report [0.03%]
伊沃西姆单抗治疗多线治疗后的EGFR突变肺腺鳞癌1例报告
Xiaohua Pan,Jianya Zhang,Chao Ye et al.
Xiaohua Pan et al.
This case report describes a 51-year-old male with advanced Epidermal Growth Factor Receptor (EGFR) mutant (p.T790M and p.L858R) lung adenosquamous carcinoma who achieved a rapid partial response (PR) to ivonescimab monotherapy following pr...
Case Report: A case of intrahepatic papillary neoplasm of the bile duct with invasive carcinoma in a young patient and review of the literature [0.03%]
胆道乳头状瘤样神经内分泌癌合并浸润性腺癌一例及文献复习
Linhui Hu,Hua Wan,Yuan Hong et al.
Linhui Hu et al.
Introduction: Intrahepatic papillary neoplasm of the bile duct (IPNB) with invasive carcinoma is a rare cholangiocarcinoma with the most frequent site of origin being intrahepatic bile ducts. Given its rarity and non-spec...
Outcomes after liposuction-based treatment of lymphedema: a systematic review and meta-analysis [0.03%]
基于吸脂术的淋巴水肿治疗效果：系统评价和 meta 分析
Junzhe Chen,Xiyao Feng,Yan Zhou et al.
Junzhe Chen et al.
Background: Lymphedema, a chronic condition involving lymphatic fluid accumulation, affects over 250 million people worldwide. Liposuction (LS), introduced in 1989, offers a minimally invasive option for non-pitting lymph...
Effect, safety, timing and dose of thoracic radiotherapy plus third-generation EGFR-TKIs as first-line treatment in patients with EGFR-mutated oligo-organ metastatic NSCLC [0.03%]
三代EGFR-TKI联合胸部放疗作为寡转移EGFR突变型晚期NSCLC一线治疗的疗效、安全性、时机及剂量探讨
Xinhang Gu,Jiaxiao Geng,Hongfu Sun et al.
Xinhang Gu et al.
Background: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-based combination therapy modalities for patients with EGFR-mutated stage IV non-small cell lung cancer (NSCLC) are being investigated. W...
Yuhan Ma,Fangfang Wang,Suling Xu
Yuhan Ma
Skin cancer is one of the most common malignant tumors worldwide, with its mortality rate showing a significant upward trend, thereby increasing the disease burden on patients and society. With the rapid development of next-generation seque...
Case Report: Stable disease achieved in a patient with metastatic castration-resistant prostate cancer following personalized treatment [0.03%]
个例报告：个性化治疗后转移去势抵抗性前列腺癌患者病情稳定
Fan Zhang,Li Zhang,Dongzi Pang et al.
Fan Zhang et al.
Castration-resistant prostate cancer (CRPC), particularly metastatic castration-resistant prostate cancer (mCRPC), is a leading cause of cancer-related death in men worldwide. Despite great achievements in the treatment of mCRPC, the clinic...
Min Pei,Xiao-Dong Dai,Xiao-Fan Jiang et al.
Min Pei et al.
Introduction: Blockade of the CD47/SIRPa axis has emerged as a promising approach to enhance macrophage-mediated anti-tumor activities in cancer immunotherapy. However, the clinical application of early CD47 antibodies ha...